154 related articles for article (PubMed ID: 2814337)
1. Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs.
Ohlsson K; Olsson R; Björk P; Balldin G; Borgström A; Lasson A; Kohno T; Thompson RC
Scand J Gastroenterol; 1989 Aug; 24(6):693-704. PubMed ID: 2814337
[TBL] [Abstract][Full Text] [Related]
2. Intrapancreatic turnover of recombinant human pancreatic secretory trypsin inhibitor in experimental porcine pancreatitis.
Jönsson P; Ohlsson K
Scand J Clin Lab Invest; 1995 May; 55(3):223-7. PubMed ID: 7638556
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic secretory proteins in sera from rats before and after induction of experimental pancreatitis.
Marks WH; Genell S; Hjelmqvist B; Ohlsson K
Scand J Gastroenterol; 1984 Jun; 19(4):552-60. PubMed ID: 6611580
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay for human pancreatic secretory trypsin inhibitor: measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases.
Kitahara T; Takatsuka Y; Fujimoto KI; Tanaka S; Ogawa M; Kosaki G
Clin Chim Acta; 1980 Apr; 103(2):135-43. PubMed ID: 6154549
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of the combined treatment of pancreatic and neutrophil elastase inhibitors on acute pancreatitis elicited by lipopolysaccharide in rats given intraductal injection of taurocholate plus trypsin.
Yamano M; Umeda M; Miyata K; Yamada T
Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):558-64. PubMed ID: 9650810
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of human pancreatic secretory trypsin inhibitor on cerulein-induced acute pancreatitis in rats.
Funakoshi A; Miyasaka K; Jimi A; Kitani K; Teraoka H; Yoshida N
Digestion; 1992; 52(3-4):145-51. PubMed ID: 1459347
[TBL] [Abstract][Full Text] [Related]
7. Do plasma and urine trypsinogen activation peptides (TAP) really increase in trypsin-taurocholate-induced pancreatitis?
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
Pancreas; 2000 May; 20(4):389-93. PubMed ID: 10824694
[TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental acute pancreatitis by intraduodenal trypsin inhibitor in rat.
Ono H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Kiriyama S; Sobajima H
Dig Dis Sci; 1990 Jun; 35(6):787-92. PubMed ID: 2344814
[TBL] [Abstract][Full Text] [Related]
9. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
Wakayama T; Itoh T; Shibayama K; Idezuki Y
Am J Gastroenterol; 1989 Mar; 84(3):272-8. PubMed ID: 2465686
[TBL] [Abstract][Full Text] [Related]
10. Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice.
Nathan JD; Romac J; Peng RY; Peyton M; Macdonald RJ; Liddle RA
Gastroenterology; 2005 Mar; 128(3):717-27. PubMed ID: 15765407
[TBL] [Abstract][Full Text] [Related]
11. Octreotide prevents L-asparaginase-induced pancreatic injury in rats.
Suzuki M; Shimizu T; Kudo T; Shoji H; Ohtsuka Y; Yamashiro Y
Exp Hematol; 2008 Feb; 36(2):172-80. PubMed ID: 18023522
[TBL] [Abstract][Full Text] [Related]
12. [The adaptive cytoprotection of exocrine pancreas in rats].
Wang LH; Yu JR; Wang CC
Sheng Li Xue Bao; 1989 Oct; 41(5):512-7. PubMed ID: 2602956
[TBL] [Abstract][Full Text] [Related]
13. A radioimmunoassay for rat pancreatic secretory trypsin inhibitor.
Marks WH; Ohlsson K
Scand J Gastroenterol; 1983 May; 18(3):401-5. PubMed ID: 6673065
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis].
Ohnishi H; Kosuzume H; Ashida Y; Kato K; Suzuki Y; Honjo I
Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):235-44. PubMed ID: 6345304
[TBL] [Abstract][Full Text] [Related]
15. [Experimental studies on the significance of the measurement of serum pancreatic secretory trypsin inhibitor in acute pancreatitis].
Tanaka T; Yamamoto M; Okumura S; Oyanagi H; Saitoh Y
Nihon Shokakibyo Gakkai Zasshi; 1985 Aug; 82(8):1914-23. PubMed ID: 4068313
[No Abstract] [Full Text] [Related]
16. Effects of chronic alcohol intake and secretory stimulation on sodium taurocholate-induced pancreatic necrosis in the rat.
Grönroos JM; Aho HJ; Nevalainen TJ
J Surg Res; 1989 Oct; 47(4):360-4. PubMed ID: 2770292
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis].
Iwaki M; Ozeki M; Sato T; Suzuki K; Motoyoshi A; Suzuki S; Fujita M; Aoyama T
Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233
[TBL] [Abstract][Full Text] [Related]
18. Activation of trypsinogen in experimental models of acute pancreatitis in rats.
Nakae Y; Naruse S; Kitagawa M; Hirao S; Yamamoto R; Hayakawa T
Pancreas; 1995 Apr; 10(3):306-13. PubMed ID: 7542773
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase regulates trypsin activation, inflammation, and tissue damage in acute pancreatitis in mice.
Hartman H; Wetterholm E; Thorlacius H; Regnér S
Dig Dis Sci; 2015 May; 60(5):1284-9. PubMed ID: 25492506
[TBL] [Abstract][Full Text] [Related]
20. Human urinary trypsin inhibitor, urinastatin, prevents pancreatic injuries induced by pancreaticobiliary duct obstruction with cerulein stimulation and systemic hypotension in the rat.
Hirano T; Manabe T
Arch Surg; 1993 Dec; 128(12):1322-9; discussion 1329. PubMed ID: 7504442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
